Literature DB >> 16364883

Heart transplantation for progressive cardiomyopathy as a manifestation of MELAS syndrome.

Rajendra S Bhati1, Brett C Sheridan, Michael R Mill, Craig H Selzman.   

Abstract

Mitochondrial diseases represent a heterogeneous group of disorders associated with a wide array of clinical manifestations. The presentation of patients with mitochondrial pathology largely depends upon the dysfunction of organ systems with large metabolic/energy requirements, including cardiac, neurologic, and musculoskeletal. In particular, mitochondrial myocardial disease can be progressive resulting in congestive heart failure and end-stage heart disease. This article reviews the role of heart transplantation for a particular variant of mitochondrial disorder, mitochondrial encephalopathy, lactic acidosis, and stroke-like episodes (MELAS) syndrome, and discusses perioperative management issues related to transplantation for mitochondrial cardiomyopathies.

Entities:  

Mesh:

Year:  2005        PMID: 16364883     DOI: 10.1016/j.healun.2005.05.012

Source DB:  PubMed          Journal:  J Heart Lung Transplant        ISSN: 1053-2498            Impact factor:   10.247


  5 in total

Review 1.  Mitochondrial medicine: to a new era of gene therapy for mitochondrial DNA mutations.

Authors:  Hélène Cwerman-Thibault; José-Alain Sahel; Marisol Corral-Debrinski
Journal:  J Inherit Metab Dis       Date:  2010-06-23       Impact factor: 4.982

Review 2.  How can we treat mitochondrial encephalomyopathies? Approaches to therapy.

Authors:  Rita Horvath; Grainne Gorman; Patrick F Chinnery
Journal:  Neurotherapeutics       Date:  2008-10       Impact factor: 7.620

3.  Heart Transplantation in Children with Mitochondrial Disease.

Authors:  Jeffrey G Weiner; Andrea N Lambert; Cary Thurm; Matt Hall; Jonathan H Soslow; Tyler E Reimschisel; David W Bearl; Debra A Dodd; Brian Feingold; Justin Godown
Journal:  J Pediatr       Date:  2019-11-08       Impact factor: 4.406

4.  A novel mitochondrial DNA deletion in a patient with Kearns-Sayre syndrome: a late-onset of the fatal cardiac conduction deficit and cardiomyopathy accompanying long-term rGH treatment.

Authors:  Monika Obara-Moszynska; Jaroslaw Maceluch; Waldemar Bobkowski; Artur Baszko; Oskar Jaremba; Maciej R Krawczynski; Marek Niedziela
Journal:  BMC Pediatr       Date:  2013-02-20       Impact factor: 2.125

5.  Multiple neurologic, psychiatric, and endocrine complaints in a young woman: a case discussion and review of the clinical features and management of mitochondrial myopathy, encephalopathy, lactic acidosis, and stroke.

Authors:  Chaya G Bhuvaneswar; Jared L Goetz; Theodore A Stern
Journal:  Prim Care Companion J Clin Psychiatry       Date:  2008
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.